Pre-market Hot Trades in US Stocks

BOXABL is down 7.03% in pre-market trading. Based on recent key news:

1. On July 27, BOXABL submitted a registration statement, planning to raise up to $500 million in securities through multiple issuances. This move may lead to market concerns about equity dilution, resulting in a drop in stock price. Source: Reuters

2. On July 27, BOXABL plans to sell up to 3.3 million shares of Class A common stock, provided by securities holders. This news may exacerbate market concerns about equity dilution, putting pressure on the stock price. Source: MT Newswires Market concerns about equity dilution have intensified.

Comfort Systems USA is up 5.06% in pre-market trading. Based on recent key news:

1. On July 30, Comfort Systems USA fell 7.37% during the day, currently reported at $1506.42. Despite the company's second-quarter earnings report showing significant revenue and net profit growth, stock sales by directors and market concerns about high valuations have pressured the stock price. Source: Zhitong Finance

2. On July 27, analysts raised the target price for Comfort Systems USA, Inc. to $2165.5, reflecting market optimism about its future growth. Source: FactSet

3. On July 29, management expects same-store revenue growth in the mid-to-high 30% range for 2026, supporting strong growth momentum. Source: Zhitong Finance Industry growth is strong, macroeconomic support is evident, and capital inflows are significant.

Top Gainers in Pre-market US Stocks

Nuwellis is up 116.40% in pre-market trading. Based on recent key news:

1. On July 27, Nuwellis reported a preliminary revenue growth of 14% for the second quarter of 2026, driving a significant increase in stock price. The company stated that this growth is mainly due to the commercial success of the Aquadex ultrafiltration platform, further enhancing market confidence.

2. On July 27, Nuwellis announced a year-on-year revenue growth of 20% for the first half of 2026, demonstrating strong market performance. This news further stimulated investor optimism, driving the stock price up.

3. On July 27, Nuwellis plans to release its complete second-quarter financial results on August 13, and the market is full of expectations for its future performance, further driving the stock price up. The medical device industry is experiencing strong growth, and the market is optimistic.

T3 Defense is up 78.61% in pre-market trading. Based on recent key news:

1. On July 29, T3 Defense completed a 1-for-125 reverse stock split, reducing the float to 1.12 million shares, triggering a technical short squeeze. The company has made operational progress in its Project 35 in the anti-drone technology field and achieved contract deliveries, further boosting market confidence. Source: Benzinga

2. On July 28, T3 Defense's subsidiary completed the delivery of an automated composite materials production line to a major Israeli manufacturer, valued at $1.1 million. This move expands the company's influence in the high-demand anti-drone technology sector. Source: Benzinga

3. On July 28, X S.E. Security and Defense Ltd. acquired a 16.67% stake in T3 Defense in exchange for Project 35 equity, and the strategic investment news boosted investor confidence. Source: Benzinga The demand for anti-drone technology is growing, and market volatility is increasing.

China Su Xuan Tang Pharmaceutical, pre-market up 52.38%, has no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation